INTEGRATED SIGMA QUANTA THERAPY AS A POSSIBLE ADJUNCT FOR TYPE 1 DIABETES: A CASE STUDY
Authors: Thornton Damon D. , Tulp Orien L. , Einstein George P. 
Published: June 2021

BackgroundRegarding juvenile onset type 1 diabetes [JIDDM], although there have been advancements in the monitoring of blood glucose [BG] levels, as well as in the delivery of insulin, the end result has essentially remained the same, in that BG levels are measured in some manner, in order to determine the dose of insulin required to attempt to maintain BG and A1C levels within normal values. The present study examined a possible methodology by which chemical, physical, and psychoneurological factors are also considered in an approach designed to diminish the dependency on insulin alone to control blood glucose in JIDDM.MethodThis study was comprised of one newly diagnosed JIDDM female (age 8 years at onset of IDDM). The participant continued her usual pre‐diabetic lifestyle, but followed a standard routine of blood glucose monitoring and appropriate administration of insulin for blood glucose management for 45 weeks. Following 45 weeks of a conventional JIDDM management routine, blood work was obtained to establish a baseline A1C. At this point, 15 weeks of additional procedures were implemented, consisting of chemical (dietary), physical (exercise/treatment modalities), and psychoneurological (anti‐stress) protocols for comparison, with blood work repeated after an additional 7.5 and 15 weeks of observation.ResultsAfter the initial 45 week period, allowing the participant to adjust to the life and routine of having IDDM, her A1C value (normal range of 4.0–5.7%) was noted to be reduced from 9.0% at the onset of JIDDM to 7.1% with conventional management of BG levels through frequent BG measurement and insulin use alone. Upon implementing the additional chemical, physical, and psychoneurological protocols for 15 weeks, the A1C value was reduced to 7.0% at the halfway point, and was further reduced to 6.8% after the 15 week period.ConclusionAn evidence‐based understanding of JIDDM, classical management through BG monitoring and insulin administration, as well as, integration of chemical, physical, and psychoneurological methods of treatment can be used to leverage improved health in JIDDM, where higher mean BG levels, as indicative with higher A1C measurements, are linked to an increased risk for various health conditions. The typical management routine over the initial 45 week period indicated a need for more frequent BG monitoring, as well as the need for more insulin when compared to the 15 week modified routine. Additionally, there was an increase in the difficulty of management of normal BG levels with the traditional JIDDM management routine. It was apparent that monitoring BG and administering insulin alone may not be the most effective approach to managing BG levels; incorporating a modified routine, with additional focus on diet, physical input, and stress reduction, improved clinical management of BG levels, and following the modified routine appeared to increase the sensitivity to insulin, whereas less insulin was required to control the BG levels in JIDDM when compared to a conventional management style.Support or Funding InformationSupported by Institutional Resources of USAT Montserrat and th Einstein Medical Institute, NPB, FL.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.